Myriad Pharmaceuticals announces strategic initiatives to focus on oncology pipeline
Myriad Pharmaceuticals, Inc. today announced several strategic initiatives to focus the Company's efforts on its oncology pipeline and to conserve its financial resources to extend the Company's projected cash runway beyond 2013.